A Multi-centre Randomised Adaptive Platform Clinical Trial to Assess Clinical, Virological and Immunological Outcomes in Patients With SARS-CoV-2 Infection (COVID-19)

Tong et al., NCT04483960, ASCOT, NCT04483960, Dec 2025
Estimated 2,200 patient paxlovid late treatment RCT with results not reported over 10 months after estimated completion.
Study covers remdesivir and paxlovid.
Tong et al., 31 Dec 2025, Randomized Controlled Trial, Australia, trial NCT04483960 (history) (ASCOT).
Late treatment
is less effective